Wednesday, March 16, 2022: Life Sciences

Pfizer and BioNTech have applied for emergency use authorization of a fourth booster dose of their Covid-19 vaccine. The companies said the additional dose is for adults 65 and older who have gotten a booster dose of any of the authorized or approved vaccines....

Wednesday, March 16, 2022: Life Sciences

The United States, European Union, South Africa, and India have reached a deal regarding intellectual property rights for COVID-19 shots. The deal would allow developing countries with low vaccine exports to use patented vaccine formulas without the owner’s...

Wednesday, March 16, 2022: Payers

The Medicare Payment Advisory Commission (MedPAC) released a new report indicating that the federal government spent $12 billion more on patients enrolled in Medicare Advantage (MA) than it would have under traditional Medicare in 2020. MedPAC told Congress the rising...